A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid Leukemia

Clinical trial NCT04694820 · COMPLETED

Trial details

NCT number: NCT04694820
Sponsor: Thomas Jefferson University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia

Start date: 2020-06-05
Primary completion: 2022-04-08
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.